Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Tesch

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Anti-Cancer Drugs|October 22, 2015
Practical experiences with eribulin in patients with metastatic breast cancerHans Tesch, Andreas Schneeweiss
Onkologie|April 4, 2013
Loss of transfusion dependency following deferasirox treatment of iron overload in a woman with myelofibrosis and spherocytosis - a case reportHans Tesch, Christian Ihling
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 12, 2023
[Anemia: Diagnostics and Therapy]Hans Tesch, Hans Tilman Steinmetz, Hartmut Link
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 24, 2021
Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicinChristian Maihöfner, Ingo Diel, Hans Tesch, et al.
Leukemia & Lymphoma|April 15, 2003
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography in lymphomaMartin R Weihrauch, Markus Dietlein, Harald Schicha, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|July 3, 2026
[Supportive care needs in patients with incurable cancer: Results of an integrative data analysis]Moritz Melcher, Lisa Tönnies, Hans Tesch, et al.
BMC Cancer|January 17, 2012
Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of lifeWolfgang Schuette, Hans Tesch, Hartwig Büttner, et al.
Breast Cancer Research and Treatment|February 20, 2025
Preferences of patients with high-risk HR + /HER2- breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from GermanyAchim Wöckel, Tjoung-Won Park-Simon, Agnieszka Korfel, et al.
The Journal of Pathology|November 13, 2004
The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphomaEva-Maria Schneider, Emina Torlakovic, Albert Stühler, et al.
Oncology Research and Treatment|April 17, 2015
Prevention and treatment of chemotherapy-induced neutropenia with the biosimilar filgrastim: a non-interventional observational study of clinical practice patternsHans Tesch, Thomas Ulshöfer, Ursula Vehling-Kaiser, et al.
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Anti-Cancer Drugs|October 22, 2015
Practical experiences with eribulin in patients with metastatic breast cancerHans Tesch, Andreas Schneeweiss
Onkologie|April 4, 2013
Loss of transfusion dependency following deferasirox treatment of iron overload in a woman with myelofibrosis and spherocytosis - a case reportHans Tesch, Christian Ihling
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 12, 2023
[Anemia: Diagnostics and Therapy]Hans Tesch, Hans Tilman Steinmetz, Hartmut Link
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 24, 2021
Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicinChristian Maihöfner, Ingo Diel, Hans Tesch, et al.
Leukemia & Lymphoma|April 15, 2003
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography in lymphomaMartin R Weihrauch, Markus Dietlein, Harald Schicha, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|July 3, 2026
[Supportive care needs in patients with incurable cancer: Results of an integrative data analysis]Moritz Melcher, Lisa Tönnies, Hans Tesch, et al.
BMC Cancer|January 17, 2012
Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of lifeWolfgang Schuette, Hans Tesch, Hartwig Büttner, et al.
Breast Cancer Research and Treatment|February 20, 2025
Preferences of patients with high-risk HR + /HER2- breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from GermanyAchim Wöckel, Tjoung-Won Park-Simon, Agnieszka Korfel, et al.
The Journal of Pathology|November 13, 2004
The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphomaEva-Maria Schneider, Emina Torlakovic, Albert Stühler, et al.
Oncology Research and Treatment|April 17, 2015
Prevention and treatment of chemotherapy-induced neutropenia with the biosimilar filgrastim: a non-interventional observational study of clinical practice patternsHans Tesch, Thomas Ulshöfer, Ursula Vehling-Kaiser, et al.
Pageof 18